ES2081308T3 - Nucleosidos fosfolipidos. - Google Patents

Nucleosidos fosfolipidos.

Info

Publication number
ES2081308T3
ES2081308T3 ES89312830T ES89312830T ES2081308T3 ES 2081308 T3 ES2081308 T3 ES 2081308T3 ES 89312830 T ES89312830 T ES 89312830T ES 89312830 T ES89312830 T ES 89312830T ES 2081308 T3 ES2081308 T3 ES 2081308T3
Authority
ES
Spain
Prior art keywords
nucleosides
phospholipid
nucleoside
difluoronucleoxides
deoxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89312830T
Other languages
English (en)
Inventor
Rosanne Bonjouklian
Gerald Burr Grindey
Larry Wayne Hertel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2081308T3 publication Critical patent/ES2081308T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LOS FOSFOLIPIDOS DE LOS 2''-DEOXI-2'',2''-DIFLUORONUCLEOXIDOS, DONDE LA MITAD QUE CONTIENE E) FOSFORO ES ENLAZADA AL OXIGENO 5''DEL NUCLEOSIDO DE FORMULA (J) SON UTILES AGENTES ANTINESPLASTICOS. EL PROCESO PARA UNA FOSFORILACION MEJORADA DEL NUCLEOSIDO USA UN GRAN EXCESO DE POCL3 DONDE R ES UNA BASE.
ES89312830T 1988-12-12 1989-12-08 Nucleosidos fosfolipidos. Expired - Lifetime ES2081308T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28276688A 1988-12-12 1988-12-12

Publications (1)

Publication Number Publication Date
ES2081308T3 true ES2081308T3 (es) 1996-03-01

Family

ID=23083035

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89312830T Expired - Lifetime ES2081308T3 (es) 1988-12-12 1989-12-08 Nucleosidos fosfolipidos.

Country Status (5)

Country Link
EP (1) EP0376518B1 (es)
JP (1) JP2817972B2 (es)
CA (1) CA2004695C (es)
DE (1) DE68924970T2 (es)
ES (1) ES2081308T3 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563257A (en) * 1990-08-20 1996-10-08 Boehringer Mannheim Gmbh Phospholipid derivatives of nucleosides
US5484911A (en) * 1993-04-01 1996-01-16 Health Research, Inc. Nucleoside 5'-diphosphate conjugates of ether lipids
AU6473098A (en) * 1997-03-24 1998-10-20 Eli Lilly And Company Difluoronucleoside phosphonic acids and derivatives thereof
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
DK1465615T3 (da) 2002-01-15 2012-11-12 Dartmouth College Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
WO2004041203A2 (en) 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
EP1464708A1 (en) * 2003-04-03 2004-10-06 Pro. Bio. Sint. S.p.A. A process for the preparation of fludarabine phosphate from 2-fluoroadenine
GB0505781D0 (en) * 2005-03-21 2005-04-27 Univ Cardiff Chemical compounds
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
EP2094651A1 (en) 2006-11-17 2009-09-02 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
WO2008064132A2 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
ME03529B (me) 2008-01-11 2020-04-20 Reata Pharmaceuticals Inc Sintetički triterpenoidi i metode njihove upotrebe u tretmanu bolesti
RS58392B1 (sr) 2008-04-18 2019-04-30 Reata Pharmaceuticals Inc Antioksidantni modulatori inflamacije: derivati oleanoličke kiseline sa amino i drugim modifikacijama na c-17
TW201006474A (en) 2008-04-18 2010-02-16 Reata Pharmaceuticals Inc Natural products including an anti-flammatory pharmacore and methods of use
EP2279197B1 (en) 2008-04-18 2014-11-05 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
HUE033288T2 (en) 2008-04-18 2017-11-28 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: C-17 homologated oleic acid derivatives
US8071632B2 (en) 2008-04-18 2011-12-06 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
WO2011017297A2 (en) 2009-08-03 2011-02-10 The University Of North Carolina At Chapel Hill Biodegradable delivery system complexes for the delivery of bioactive compounds
EP2833905B1 (en) 2012-04-04 2018-05-02 Halozyme, Inc. Combination therapy with hyaluronidase and a tumor-targeted taxane
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
EP3618837A4 (en) 2017-04-26 2020-11-04 Thomas I. Kalman MULTI-DIRECTIONAL NUCLEOSIDE DERIVATIVES
WO2019222435A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
WO2020041051A1 (en) * 2018-08-20 2020-02-27 Cure Biopharma Inc. Gemcitabine prodrugs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587500T2 (de) * 1984-12-04 1993-12-16 Lilly Co Eli Tumorbehandlung bei Säugetieren.
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
DE3778626D1 (de) * 1986-09-27 1992-06-04 Toyo Jozo Kk Nukleosid-phospholipid-konjugat.

Also Published As

Publication number Publication date
CA2004695C (en) 1999-08-10
JPH02202896A (ja) 1990-08-10
CA2004695A1 (en) 1990-06-12
JP2817972B2 (ja) 1998-10-30
DE68924970D1 (de) 1996-01-11
EP0376518B1 (en) 1995-11-29
EP0376518A1 (en) 1990-07-04
DE68924970T2 (de) 1996-05-15

Similar Documents

Publication Publication Date Title
ES2131116T3 (es) Analogos de nucleotidos enantiomericos antirretrovirales.
ES2017611T3 (es) Tiazoles sustituidos y su uso como fungicidas.
ES2100907T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion.
ES2035002T3 (es) Mezclas de colorantes.
ES2150577T3 (es) Aminoeteres aromaticos como agentes para aliviar el dolor.
ES8602840A1 (es) Un procedimiento para la preparacion de un nucleosido.
ES2066461T3 (es) Nuevos derivados fosfolipidicos de nucleosidos, su preparacion, asi como su utilizacion como medicamentos antiviricos.
ES2104733T3 (es) Derivados de indol.
PT1229040E (pt) Derivados nucleosido-monofosfato processo para a sua producao e sua utilizacao como farmacos imunossupressores
ES2032456T3 (es) Procedimiento para preparar derivados de 1,2,5,6-tetrahidropiridin-3-carboxaldehido-oxima.
ES2066806T3 (es) Uso de la adenosina 5'-fosfato para el tratamiento de caquexia de cancer.
ES2014523A6 (es) Procedimiento de preparar derivados de aril-heteroarilcarbinoles.
CA2004695A1 (en) Phospholipid nucleosides
ES2061559T3 (es) Triazolinonas substituidas.
ES2091236T3 (es) Composiciones de lubricantes.
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES8606297A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimidazo(2,1-b) quinazolinil)-oxialquilamidas
MX168931B (es) Procedimiento para preparar compuestos de organofosforo
AR240924A2 (es) "procedimiento para preparar derivados de 1,3-oxazolidin-2-ona y sus sales".
ES2102870T3 (es) Benzopiranos y composiciones farmaceuticas que los contienen.
FI832832A0 (fi) Substituerad 9-(1-0- eller 3-0-monosubstituerad eller 1,3-d1-0-substituerad propoxymetyl)-puriner som antiviral agenter
ES2038794T3 (es) Procedimiento para la obtencion de derivados del azolil-propenil- y azolilmetiloxirano y fungicidas que les contienen.
PT82547B (pt) Processo de preparacao de acidos hexenoicos e de composicoes farmaceuticas que os contem
ES2051846T3 (es) 3,4-dihidro-2-alquil-3-oxo-n-aril-2h-(1)benzotieno(3,2-e)-1,2-tiazino-4-carboxamido-1,1-dioxidos.
ES2105596T3 (es) Procedimiento para la preparacion de un acido oxazolidina-1,3-carboxilico-5.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 376518

Country of ref document: ES